Systematic high-throughput drug sensitivity and resistance testing (DSRT) of ovarian cancer cell lines indicates novel therapeutic possibilities with existing and emerging drugs




Hirasawa A, Murumagi A, Arjama M, Yadav B, Mpindi JP, Wennerberg K, Aittokallio T, Aoki D, Kallioniemi O

PublisherAMER ASSOC CANCER RESEARCH

2014

Cancer Research

CANCER RESEARCH

CANCER RES

74

19

1

0008-5472

DOIhttps://doi.org/10.1158/1538-7445.AM2014-5384




Last updated on 2024-26-11 at 22:42